BOK Cancer Research Results
BOK, Bcl-2-related ovarian killer: Click to Expand ⟱
| Source: |
| Type: |
BOK (Bcl-2-related ovarian killer) is a member of the Bcl-2 family of proteins and is generally considered a pro-apoptotic factor.
BOK is categorized as a pro-apoptotic protein and is thought to contribute to the intrinsic (mitochondrial) pathway of apoptosis.
Although direct targeting of BOK is not yet well established, restoring or enhancing its expression in tumors with low BOK levels could be a strategy to re-sensitize cancer cells to apoptosis.
Alterations in BOK expression have been observed in several types of cancers. In some tumor models, downregulation or loss of BOK expression may be associated with reduced apoptotic response, which can contribute to uncontrolled cell survival.
|
Scientific Papers found: Click to Expand⟱
tumCV↓, BAX↑, BID↑, BOK↑, APAF1↑, TNF-α↑, FasL↑, Fas↑, FADD↑, Casp3↑, Casp7↑, Casp8↑, Casp9↑, Mcl-1↓, NAIP↓, Bcl-2↓, CDK4↓, CycB/CCNB1↓, cycD1/CCND1↓, cycE1↓, TRAIL↑, p‑Akt↓, Akt↓, mTOR↓, PDK1↓, BAD↓, GSK‐3β↑, AMPK↑, p27↑, P53↑,
ROS↑, TumCCA↑, TumCP↓, angioG↓, ER Stress↑, mtDam↑, PERK↑, ATF4↑, eIF2α↑, cl‑Casp12↑, EMT↓, E-cadherin↑, N-cadherin↓, Vim↓, *neuroP↑, NF-kB↓, PI3K↓, Akt↑, XIAP↓, MMP↓, Ca+2↑, BAX↑, Casp3↑, Casp9↑, Bcl-2↓, Cyt‑c↑, IronCh↑, SOD↓, *ROS↓, *LDHA↑, *SOD↑, *GSH↑, *BioAv↓, Telomerase↓, cMyc↓, hTERT/TERT↓, DR5↑, Fas↑, FADD↑, BAD↑, BOK↑, BID↑, NAIP↓, Mcl-1↓, CDK2↓, CDK4↓, MAPK↓, AKT1↓, Akt2↓, *Beclin-1↓, Hif1a↓, LC3II↑, Beclin-1↑,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 1, SOD↓, 1,
Metal & Cofactor Biology ⓘ
IronCh↑, 1,
Mitochondria & Bioenergetics ⓘ
BOK↑, 2, MMP↓, 1, mtDam↑, 1, XIAP↓, 1,
Core Metabolism/Glycolysis ⓘ
AKT1↓, 1, AMPK↑, 1, cMyc↓, 1, PDK1↓, 1,
Cell Death ⓘ
Akt↓, 1, Akt↑, 1, p‑Akt↓, 1, APAF1↑, 1, BAD↓, 1, BAD↑, 1, BAX↑, 2, Bcl-2↓, 2, BID↑, 2, cl‑Casp12↑, 1, Casp3↑, 2, Casp7↑, 1, Casp8↑, 1, Casp9↑, 2, Cyt‑c↑, 1, DR5↑, 1, FADD↑, 2, Fas↑, 2, FasL↑, 1, hTERT/TERT↓, 1, MAPK↓, 1, Mcl-1↓, 2, NAIP↓, 2, p27↑, 1, Telomerase↓, 1, TRAIL↑, 1,
Transcription & Epigenetics ⓘ
tumCV↓, 1,
Protein Folding & ER Stress ⓘ
eIF2α↑, 1, ER Stress↑, 1, PERK↑, 1,
Autophagy & Lysosomes ⓘ
Beclin-1↑, 1, LC3II↑, 1,
DNA Damage & Repair ⓘ
P53↑, 1,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, CDK4↓, 2, CycB/CCNB1↓, 1, cycD1/CCND1↓, 1, cycE1↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1, GSK‐3β↑, 1, mTOR↓, 1, PI3K↓, 1,
Migration ⓘ
Akt2↓, 1, Ca+2↑, 1, E-cadherin↑, 1, N-cadherin↓, 1, TumCP↓, 1, Vim↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, ATF4↑, 1, Hif1a↓, 1,
Immune & Inflammatory Signaling ⓘ
NF-kB↓, 1, TNF-α↑, 1,
Clinical Biomarkers ⓘ
hTERT/TERT↓, 1,
Total Targets: 66
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
GSH↑, 1, ROS↓, 1, SOD↑, 1,
Core Metabolism/Glycolysis ⓘ
LDHA↑, 1,
Autophagy & Lysosomes ⓘ
Beclin-1↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1,
Functional Outcomes ⓘ
neuroP↑, 1,
Total Targets: 7
Scientific Paper Hit Count for: BOK, Bcl-2-related ovarian killer
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1018 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page